A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells

被引:0
|
作者
Jacqui A. McGovern
Nathalie Bock
Abbas Shafiee
Laure C. Martine
Ferdinand Wagner
Jeremy G. Baldwin
Marietta Landgraf
Christoph A. Lahr
Christoph Meinert
Elizabeth D. Williams
Pamela M. Pollock
Jim Denham
Pamela J. Russell
Gail P. Risbridger
Judith A. Clements
Daniela Loessner
Boris M. Holzapfel
Dietmar W. Hutmacher
机构
[1] Queensland University of Technology (QUT),Centre in Regenerative Medicine
[2] Centre for Biomedical Technologies,School of Mechanical, Medical and Process Engineering (MMPE)
[3] Faculty of Engineering,School of Biomedical Sciences at Translational Research Institute (TRI)
[4] QUT,Australian Prostate Cancer Research Centre—Queensland (APCRC
[5] Faculty of Health,Q)
[6] QUT,UQ Diamantina Institute, Translational Research Institute
[7] QUT,Herston Biofabrication Institute
[8] Queensland Bladder Cancer Initiative (QBCI),Musculoskeletal University Centre Munich, Department of Orthopedics and Trauma Surgery
[9] The University of Queensland,Department of Pediatric Surgery, Dr. von Hauner Children’s Hospital
[10] Metro North Hospital and Health Service,School of Medicine and Population Health
[11] University Hospital Munich,Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences
[12] Ludwig-Maximilians University,Department of Chemical Engineering and Department of Materials Science and Engineering, Faculty of Engineering
[13] Campus Großhadern,ARC Industrial Transformation Training Centre in Additive Biomanufacturing
[14] Ludwig-Maximilians-University of Munich,undefined
[15] University of Newcastle,undefined
[16] Monash University,undefined
[17] Monash University,undefined
[18] QUT,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Prostate cancer (PCa) is the second most commonly diagnosed cancer in men, and bone is the most frequent site of metastasis. The tumor microenvironment (TME) impacts tumor growth and metastasis, yet the role of the TME in PCa metastasis to bone is not fully understood. We used a tissue-engineered xenograft approach in NOD-scid IL2Rγnull (NSG) mice to incorporate two levels of humanization; the primary tumor and TME, and the secondary metastatic bone organ. Bioluminescent imaging, histology, and immunohistochemistry were used to study metastasis of human PC-3 and LNCaP PCa cells from the prostate to tissue-engineered bone. Here we show pre-seeding scaffolds with human osteoblasts increases the human cellular and extracellular matrix content of bone constructs, compared to unseeded scaffolds. The humanized prostate TME showed a trend to decrease metastasis of PC-3 PCa cells to the tissue-engineered bone, but did not affect the metastatic potential of PCa cells to the endogenous murine bones or organs. On the other hand, the humanized TME enhanced LNCaP tumor growth and metastasis to humanized and murine bone. Together this demonstrates the importance of the TME in PCa bone tropism, although further investigations are needed to delineate specific roles of the TME components in this context.
引用
收藏
相关论文
共 50 条
  • [21] Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer
    Yousefieh, Nazita
    Hahto, Suzanne M.
    Stephens, Amber L.
    Ciavarra, Richard P.
    CANCER MICROENVIRONMENT, 2009, 2 (01) : 59 - 67
  • [22] Impact of Immune Cells in the Tumor Microenvironment of Prostate Cancer Metastasis
    Messex, Justin K.
    Liou, Geou-Yarh
    LIFE-BASEL, 2023, 13 (02):
  • [23] A multidisciplinary approach to treating the tumor-microenvironment interactions of metastatic prostate cancer
    Pienta, KJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P1 - P1
  • [24] Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment
    Sun, Belinda L.
    PROSTATE, 2021, 81 (15): : 1125 - 1134
  • [25] Bone Marrow on a Chip: a novel microphysiological system for the study of the prostate cancer metastatic bone microenvironment
    Sanchez-de-Diego, Cristina
    Kerr, Sheena C.
    Sethakorn, Nan
    Yada, Ravi Chandra
    Virumbrales-Munoz, Maria
    Ding, Adeline
    Hermes, Brock
    Heninger, Erika
    Lang, Joshua M.
    Beebe, David J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 125 - 125
  • [26] The alpha receptor for Platelet-Derived Growth Factor is determinant for the bone-tropism of metastatic prostate cancer cells.
    Russell, Mike
    Jamieson, Whitney
    Fatatis, Alessandro
    CANCER RESEARCH, 2008, 68 (09)
  • [27] Effects of cytoreductive primary tumor resection in an orthotopic mouse model of metastatic prostate cancer
    Linxweiler, J.
    Hajili, T.
    Koerbel, C.
    Zeuschner, P.
    Menger, M. D.
    Stoeckle, M.
    Junker, K.
    Saar, M.
    EUROPEAN UROLOGY, 2021, 79 : S592 - S592
  • [28] Glypican-1: A tumor suppressor or an oncogene in human bone metastatic prostate cancer cells
    Quach, Nhat D.
    Eggert, Matthew
    Ghosh, Deepraj
    Dawson, Michelle R.
    Arnold, Robert
    Cummings, Brian S.
    CANCER RESEARCH, 2017, 77
  • [29] Overexpression of Axl delays metastatic outgrowth of prostate cancer bone marrow disseminated tumor cells
    Axelrod, Haley D.
    Valkenburg, Kenneth C.
    Pienta, Kenneth J.
    CANCER RESEARCH, 2016, 76
  • [30] Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models
    Glinskii, AB
    Smith, BA
    Jiang, P
    Li, XM
    Yang, M
    Hoffman, RM
    Glinsky, GV
    CANCER RESEARCH, 2003, 63 (14) : 4239 - 4243